Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615219-16-000112
Filing Date
2016-03-08
Accepted
2016-03-08 07:17:29
Documents
2
Period of Report
2016-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_145743943745457.html 3  
1 FORM 3 wf-form3_145743943745457.xml 3 1704
2 STACY POWER OF ATTORNEY powerofattorney.htm EX-24 3210
  Complete submission text file 0001615219-16-000112.txt   6257
Mailing Address 33 COFFEE LANE WATERBURY VT 05676
Business Address
Stacy Michelle (Reporting) CIK: 0001448355 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36812 | Film No.: 161490288

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations